Literature DB >> 17509568

The complex aetiology of frontotemporal lobar degeneration.

Stuart M Pickering-Brown1.   

Abstract

Frontotemporal lobar degeneration (FTLD) is now a widely recognised form of dementia. This heterogeneous disease has been of particular interest to geneticists due to its high rate of heritability with up to 40% of patients reporting a family history of the disease in at least one extra family member. There have been several chromosome loci linked to this disorder and three genes have already been identified. Remarkably, it has been recently demonstrated that 2 of these are only 1.7 Mb from one another on chromosome 17q21, these being tau and progranulin. The identification of these genes has contributed greatly to our understanding of the differing neuropathologies associated with FTLD. Furthermore, the discovery that TDP-43 is a component of the neuronal inclusions seen in the most common neuropathological subtype has also helped expand the biochemical pathways that are the focus of much FTLD research. Nevertheless, other genes causing FTLD remain to be identified and their biology elucidated before we have a complete understanding of the complex aetiology of this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509568     DOI: 10.1016/j.expneurol.2007.03.017

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  12 in total

1.  Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.

Authors:  E Gordon; J D Rohrer; L G Kim; R Omar; M N Rossor; N C Fox; J D Warren
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

Review 2.  Frontotemporal lobar degeneration: current knowledge and future challenges.

Authors:  Chiara Cerami; Elio Scarpini; Stefano F Cappa; Daniela Galimberti
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

3.  Frontotemporal dementia: An updated overview.

Authors:  E Mohandas; V Rajmohan
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

Review 4.  Clinical phenotypes and genetic biomarkers of FTLD.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  J Neural Transm (Vienna)       Date:  2012-04-19       Impact factor: 3.575

5.  Genetics of frontotemporal lobar degeneration.

Authors:  P M Aswathy; P S Jairani; P S Mathuranath
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

6.  [Frontotemporal dementia in association with a family history of dementia and ApoE polymorphism].

Authors:  M Zintl; M Petkov; G Schmitz; G Hajak; H-H Klünemann
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

7.  Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration.

Authors:  Sara Rollinson; Patrizia Rizzu; Stephen Sikkink; Matthew Baker; Nicola Halliwell; Julie Snowden; Bryan J Traynor; Dina Ruano; Nigel Cairns; Jonathan D Rohrer; Simon Mead; John Collinge; Martin Rossor; Ela Akay; Rita Guerreiro; Rosa Rademakers; Karen E Morrison; Pau Pastor; Elena Alonso; Pablo Martinez-Lage; Neil Graff-Radford; David Neary; Peter Heutink; David M A Mann; John Van Swieten; Stuart M Pickering-Brown
Journal:  Neurobiol Aging       Date:  2009-02-12       Impact factor: 4.673

8.  Structural brain changes in First Episode Schizophrenia compared with Fronto-Temporal Lobar Degeneration: a meta-analysis.

Authors:  Bayanne Olabi; Ian Ellison-Wright; Ed Bullmore; Stephen M Lawrie
Journal:  BMC Psychiatry       Date:  2012-08-07       Impact factor: 3.630

9.  Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.

Authors:  Janet van Eersel; Yazi D Ke; Amadeus Gladbach; Mian Bi; Jürgen Götz; Jillian J Kril; Lars M Ittner
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

10.  Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations.

Authors:  Jonathan D Rohrer; Gerard R Ridgway; Marc Modat; Sebastien Ourselin; Simon Mead; Nick C Fox; Martin N Rossor; Jason D Warren
Journal:  Neuroimage       Date:  2010-01-04       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.